Evidence map›Paper›PMID 34663844›Full record

ArticleScientific reports2021

Aronia melanocarpa polysaccharide ameliorates inflammation and aging in mice by modulating the AMPK/SIRT1/NF-κB signaling pathway and gut microbiota.

Yingchun Zhao, Xinglong Liu, Yinan Zheng, Wencong Liu, Chuanbo Ding

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 72 citations in OpenAlex.

  1. Extract fromNutrients · 2024
    Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. A Review ofFoods (Basel, Switzerland) · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Polyphenols, Polysaccharides, and Their Complexes fromMolecules (Basel, Switzerland) · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yingchun Zhao *College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Xinglong Liu *College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Yinan Zheng *College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Wencong LiuCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China. jwlw6803@126.com.
Chuanbo DingCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China. chuanboding0506@163.com.
Jilin Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aronia melanocarpa is a natural medicinal plant that has a variety of biological activities, its fruit is often used for food and medicine. Aronia melanocarpa polysaccharide (AMP) is the main component of the Aronia melanocarpa fruit. This research evaluated the delay and protection of AMP obtained from Aronia melanocarpa fruit on aging mice by D-Galactose (D-Gal) induction and explored the effect of supplementing AMP on the metabolism of the intestinal flora of aging mice. The aging model was established by intraperitoneal injection of D-Gal (200 mg/kg to 1000 mg/kg) once per 3 days for 12 weeks. AMP (100 and 200 mg/kg) was given daily by oral gavage after 6 weeks of D-Gal-induced. The results showed that AMP treatment significantly improved the spatial learning and memory impairment of aging mice determined by the eight-arm maze test. H&E staining showed that AMP significantly reversed brain tissue pathological damage and structural disorders. AMP alleviated inflammation and oxidative stress injury in aging brain tissue by regulating the AMPK/SIRT1/NF-κB and Nrf2/HO-1 signaling pathways. Particularly, AMP reduced brain cell apoptosis and neurological deficits by activating the PI3K/AKT/mTOR signaling pathway and its downstream apoptotic protein family. Importantly, 16S rDNA analysis indicated the AMP treatment significantly retarded the aging process by improving the composition of intestinal flora and abundance of beneficial bacteria. In summary, this study found that AMP delayed brain aging in mice by inhibiting inflammation and regulating intestinal microbes, which providing the possibility for the amelioration and treatment of aging and related metabolic diseases.

Indexed as

Adenylate KinaseAgingAMP-Activated Protein KinasesAnimalsGastrointestinal MicrobiomeInflammationMaleMemoryMiceMice, Inbred ICRNF-kappa BPhosphatidylinositol 3-KinasesPhotiniaPlant ExtractsPolysaccharidesSignal TransductionAdenylate KinaseAMP-Activated Protein KinasesNF-kappa BPhosphatidylinositol 3-KinasesPlant ExtractsPolysaccharidesSirt1 protein, mouseSirtuin 1

Identifiers

PMID34663844
PMCPMC8523697
OpenAlexW3189795024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.